Michael R. Bristow, President and CEO at ARCA biopharma, Inc. (ABIO), sold 13,853 shares at $1.30 ($18K) on 2014-09-18, disclosed to the SEC on 2014-09-19.
Scheduled sale ($18k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABIO | SELL | 2016-09-21 | $6K | — | Filing → |
| ABIO | SELL | 2016-04-06 | $3K | — | Filing → |
| ABIO | SELL | 2016-03-02 | $3K | — | Filing → |